Live-cell imaging of cytoskeletal dynamics and granule movement during stimulation of mast cells. by Jeremies Ibanga (12275230)

Subjects:

Knock-down of the kinesin-1 heavy chain, Kif5b, inhibits granule translocation to the plasma membrane and exocytosis. by Jeremies Ibanga (12275230)

Subjects:

qPCR primers for Kinesin-1 cargo adaptor proteins. by Jeremies Ibanga (12275230)

Subjects:

Kinesore treatment of mast cells affects microtubule structures independent of its effect on granule distribution. by Jeremies Ibanga (12275230)

Subjects:

Kinesore, a small-molecule activator of microtubule motors, inhibits mast cell granule exocytosis. by Jeremies Ibanga (12275230)

Subjects:

Microtubule drugs inhibit mast cell granule exocytosis and affect granule motility. by Jeremies Ibanga (12275230)

Subjects:

Microtubule drugs and the microtubule motor drugs, kinesore, affects cell morphology and granule distribution but not F-actin remodeling. by Jeremies Ibanga (12275230)

Subjects:

Kinesore inhibits granule association of the microtubule motor kinesin-1. by Jeremies Ibanga (12275230)

Subjects:

Quantification of perinuclear-retained CD63 signal in antigen-stimulated RBL-2H3 cells. by Jeremies Ibanga (12275230)

Subjects:

Baseline level biochemical and circulating biomarkers in study subjects. by Jaskiran Kaur (160829)

Subjects:

Represents the levels of biomarkers as baseline and follow up in placebo and cholecalciferol group. by Jaskiran Kaur (160829)

Subjects:

CONSORT flowchart. by Jaskiran Kaur (160829)

Subjects:

Change in serum levels of vitamin D and angiogenic marker at 16 weeks follow-up. by Jaskiran Kaur (160829)

Subjects:

Baseline characteristics of study subjects. by Jaskiran Kaur (160829)

Subjects: